Training Blog

Painkiller Ban reduces suicide

by Kirsty on Jun.19, 2009, under Healthcare News

The painkiller co-proxamol has been gradually phased out after its licence was removed in 2007, since then there have been 350 fewer suicides and accidental deaths. The reason the drug was banned was due to the fact that studies such as that done by Professor Keith Hawton of Oxford University showed that co-proxamol was responsible for one fifth of drug related suicides.

Co-proxamol is a mixture of paracetamol and an opiod drug called dextropropoxyphene. It was used to manage the pain in conditions such as arthritis. Co-proxamol is extremely dangerous as even a slight overdose can be fatal as it takes effect very quickly so death occurs before medical attention can be sought.

Since the licence was removed there is a system in place where doctors could prescribe the drug on a named patient basis. This is for patients who are unable to manage their pain using alternatives, although they do so at there own risk because it is an unlicensed drug.

It seems that with any drug there is the risk of an overdose just so happens that the media found out about this one and created alot of hype otherwise known as a moral panic which then caused the regulators to remove it. If that’s the case then why not move drugs such as aspirin, that are readily available because if somebody decides that they want to commit suicide then they will do so using any means at their disposal, so are the regulators going to slowly ban every drug and put it on a named patient only system. This will not only cause problems for people who wish to gain access to analgesia or other fairly routine medication such as hayfever remedies, also it will cause the pharmaceutical companies to lose billions as the number of their product sold will decrease.


Leave a Reply